IT - EN - DE     Finceramica




Lunch Symposium An Evidence based Step Ahead in the Treatment of OC Lesions Results of an International RCT

 Finceramica welcome you to this Lunch Symposium where the results from our International Study comparing MaioRegen bio-mimetic osteochondral scaffold to bone marrow stimulation techniques will be officially presented.

This Level of Evidence 1 Randomized Controlled Trial confirms MaioRegen as a “step ahead” in the treatment of osteochondral lesions.

We are looking forward to sharing these important results with you!



Finceramica selected as a finalist in the GOOD Company Project by IBM, GOOD's partner


MaioRegen WEB Registry

1  2  3  4  5